alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › placebo-controlled

placebo-controlled

804 studies tagged placebo-controlled, dated 1986-01-01 to 2026-09-22. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial 2026-09-22
  2. Varenicline as a Repurposable Drug Candidate for ADRD Prevention 2026-09-20
  3. Antihypertensive Medication Class and Incident Alzheimers Disease and Related Dementias: External Replication Across Two Independent Healthcare Data Sources-the Vanderbilt EHR Synthetic Derivative and US Medicare Claims 2026-09-17

Studies

804 studies carry this tag.

Date range

1986 to 2026

Top journals

  • Neurology 66
  • The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 35
  • JAMA 24
  • JAMA neurology 23
  • Alzheimer's research & therapy 21

333 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Selegiline in the treatment of mild to moderate Alzheimer-type dementia

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Clinical therapeutics 1990-07-01 Treatments

    Selegiline, an inhibitor of monoamine oxidase B, was tested on patients with mild to moderate dementia of the Alzheimer type.

  2. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Current medical research and opinion 1990-01-01 Treatments

    A randomized, double-blind, placebo-controlled, parallel-group clinical trial was carried out to compare 24-week periods of treatment with 1 g acetyl-l-carnitine twice daily and placebo in the treatment of patients with dementia of the Alzheimer type.

  3. Pharmacologic treatment of agitation associated with dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of the American Geriatrics Society 1986-05-01 Disparities

    Pharmacotherapy of aggressive or agitated behaviors in the dementia patient has not been studied extensively, despite the prevalence of this problem.

  4. Memantine in the treatment of senile dementia of the Alzheimer type

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Progress in neuro-psychopharmacology & biological psychiatry 1986-01-01 Treatments

    The efficacy of the dopaminergic substance Memantine was studied in severe cases of senile dementia of the Alzheimer type using a randomized single blind trial.

From across this tag

10 of the 795 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

All topic tags with their study counts